Skip to content
Open·Listed in the source's current feed today

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

National Institutes of Health

Apply at National Institutes of Health

Want a reminder before this closes?

We'll email you 3 days before the deadline. One email, then we stop.

Free. Verify your email, then we send one reminder only.

Posted
Dec 17, 2025
Closes
Jan 7, 2028 (in 449 days)

See more open grant funding like this

Get alerted when new grant funding matching "modular cancer control" opens, nationwide.

Checking your account…

Free includes 1 alert. New listings reach free search, alerts and AI search after 10 days. Unsubscribe anytime.

Classification and identifiers

Solicitation number
PA-25-172
Assistance listing (CFDA)
93.399

Amount

Amount not listed here. Check the official program.

Who can apply

Tribal organizationsPrivate universitiesCounty governmentsNonprofits (non-501c3)Local governmentsState governments

Private colleges and universities, Local government agencies, and State government agencies can all apply here. Check the eligibility details below to see if your organization fits.

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

About this opportunity

This Notice of Funding Opportunity (NOFO) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, healthcare delivery, and digital health and data science, and implementation science.

Refine this search